Clinical Trial

Genetic and Functional Analysis of Cherubism

Study acronym: CBM
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this research study is to identify genes and regulatory elements on chromosomes that cause cherubism. Together with the investigators collaborators the investigators also study blood samples and tissue samples from patients to learn about the processes that lead to this disorder. The long-term goal of researchers involved in this study is to find mechanisms to slow down bone resorption in cherubism patients.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2012-06-27; most recent amendment 2026-04-14.
Trial Details
NCT Number NCT01630447
Lead Sponsor UConn Health
Conditions Cherubism
Enrollment 600 participants
Start Date 2009-04
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-15